EMG Biofeedback and NMES of Deltoid in Patients With rTSA

March 6, 2025 updated by: National Taiwan University Hospital

Electromyography Biofeedback and Neuromuscular Electrical Stimulation of Deltoid in Patients With Reverse Total Shoulder Arthroplasty

The effect of NMES and surface electromyography (sEMG) biofeedback on the deltoid and associated scapular muscles in scapular kinematics and muscle activation in individual post rTSA

Study Overview

Detailed Description

Reverse total shoulder arthroplasty (rTSA) has been the optimal treatment for massive irreparable rotator cuff tears and cuff tear arthropathy. Since scapular kinematics alteration was associated with shoulder disorders, scapular kinematics had been characterized in individuals post rTSA with more upward rotation, external rotation, and posterior tilt of the scapula. In addition, the average scapulohumeral rhythm ranged from 1.1 to 1.6, indicating lower glenohumeral joint movements and higher scapulothoracic movements. It supposed that more scapula upward rotation without adequate humeral elevation can result in the scapula notching. Therefore, strategy to decrease scapular movement or increase humeral movements during arm movements may prevent scapula notching. To compensate for rotator cuff deficiency, the deltoid muscle plays a crucial role post rTSA. Enhancing deltoid function can be accomplished through the use of biofeedback or neuromuscular electrical stimulation (NMES). However, the effect of NMES and surface electromyography (sEMG) biofeedback on the deltoid and associated scapular muscles in scapular kinematics, muscle activation, and muscle balance ratio in individual post rTSA remained unclear. Therefore, the objectives in this study would to (1) determine the immediate effects of NMES with EMG biofeedback to deltoid (D) on the muscle activation of upper trapezius (UT), lower Trapezius (LT) and serratus Anterior (SA) as well as the scapular kinematics (upward/downward rotation, external/internal rotation, anterior/posterior tilting) (2) evaluate the immediate effects of NMES with EMG biofeedback on the muscle balance ratios (D/UT, D/LT, D/SA) and the scapulohumeral rhythm (SHR) during arm elevation in the scapular plane at different range of motion.

Study Type

Interventional

Enrollment (Estimated)

34

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Zhongzheng Dist.
      • Taipei City, Zhongzheng Dist., Taiwan, 100
        • Recruiting
        • National Taiwan University of school and graduate of physical therapy of Performance Analysis Laboratory
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • (1) age between 20 to 85 years old
  • (2) undergoing primary reverse shoulder arthroplasty
  • (3) shoulder abduction in scapular plane above 90 degrees
  • (4) above 3 months following rTSA

Exclusion Criteria:

  • (1) a history of other shoulder surgery on the rTSA shoulder
  • (2) a revision rTSA
  • (3) a surgery shoulder muscle tendon transfer
  • (4) neuromuscular diseases
  • (5) cognitive disorders
  • (6) contraindications for NMES

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: biofeedback
sEMG biofeedback: Subjects were instructed to monitor the sEMG signals of the D/UT balances ratio on the screen and maintain the D/UT balances ratio above the threshold during arm elevation and lowering. The threshold was set at 1 standard deviation of the ratio average at baseline (before intervention).
sEMG biofeedback: Subjects were instructed to monitor the sEMG signals of the D/UT balances ratio on the screen and maintain the D/UT balances ratio above the threshold during arm elevation and lowering. The threshold was set at 1 standard deviation of the ratio average at baseline (before intervention).
Experimental: neuromuscular electrical stimulation
NMES: Two electrode pads were placed on the anterior, middle, and posterior deltoid boundary lines and at a distance of 1cm distal to the lateral margin of the acromion. The operator palpated the deltoid muscle contraction and asked the subjects to perform arm elevation task with NMES. (frequency of 35 Hz and a duration of 250 microseconds.) A verbal cue was given during both th A verbal cue was given during both the sEMG biofeedback and NMES interventions: "Lengthen your arm as if you want to touch the ground, the scapula keeps in the neutral position, and then elevate your arm." Each intervention consisted of 3 sets of 10 repetitions per set, with a 1-minute rest between sets.

NMES: Two electrode pads were placed on the anterior, middle, and posterior deltoid boundary lines and at a distance of 1cm distal to the lateral margin of the acromion. The operator palpated the deltoid muscle contraction and asked the subjects to perform arm elevation task with NMES. (frequency of 35 Hz and a duration of 250 microseconds.) A verbal cue was given during both th

A verbal cue was given during both the sEMG biofeedback and NMES interventions: "Lengthen your arm as if you want to touch the ground, the scapula keeps in the neutral position, and then elevate your arm." Each intervention consisted of 3 sets of 10 repetitions per set, with a 1-minute rest between sets.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle activation
Time Frame: before intervention (baseline) and through intervention completion, an average 15 minutes in each intervention (sEMG biofeedback or NMES)
Muscle activation The muscle activation of upper trapezius, lower trapezius, serrates anterior, and deltoid were collected during arm elevation task by sEMG at baseline, post- sEMG biofeedback, and post- NMES. Muscle activation was analyzed based on 0°-30°, 30°-60°, and 60°-90° during arm elevation and lowering. The sEMG data was calculated using the root mean square (RMS) based on average of middle three from five trials. The MVIC of UT, LT, SA, and D were used to normalize the sEMG data.
before intervention (baseline) and through intervention completion, an average 15 minutes in each intervention (sEMG biofeedback or NMES)
Scapular kinematics
Time Frame: before intervention (baseline) and through intervention completion, an average 15 minutes in each intervention (sEMG biofeedback or NMES)
Scapular kinematics The scapular kinematics during arm elevation task was captured using an electromagnetic motion analysis system. The three scapula orientations were described using the Euler angle sequence with an X-axis for scapular posterior/anterior tilt, Y-axis for scapular upward/downward rotation, and Z-axis for scapular internal/external rotation. The average of middle three from five trials on scapular kinematics were analyzed at 30°, 60°, and 90° arm elevation and lowering.
before intervention (baseline) and through intervention completion, an average 15 minutes in each intervention (sEMG biofeedback or NMES)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle balance ratios
Time Frame: before intervention (baseline) and through intervention completion, an average 15 minutes in each intervention (sEMG biofeedback or NMES)
Muscle balance ratios The muscle balance ratios of D/UT, D/LT, and D/SA were calculated based on average of middle three from five trials at the phases of 0°-30°, 30°-60°, and 60°-90° during arm elevation and lowering phase.
before intervention (baseline) and through intervention completion, an average 15 minutes in each intervention (sEMG biofeedback or NMES)
Scapulohumeral rhythm
Time Frame: before intervention (baseline) and through intervention completion, an average 15 minutes in each intervention (sEMG biofeedback or NMES)
Scapulohumeral rhythm The scapulohumeral rhythm data was collected by humeral elevation relative to scapular upward rotation at the phases of 30°, 60°, and 90° arm elevation and lowering in scapular plane. The data was based on average of middle three from five trials.
before intervention (baseline) and through intervention completion, an average 15 minutes in each intervention (sEMG biofeedback or NMES)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Jiu-Jenq Lin, Ph.D, School and Graduate Institute of Physical Therapy, College of Medicine, National Taiwan University, Taipei, Taiwan

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 15, 2025

Primary Completion (Estimated)

May 20, 2025

Study Completion (Estimated)

May 20, 2025

Study Registration Dates

First Submitted

February 17, 2025

First Submitted That Met QC Criteria

March 6, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 6, 2025

Last Verified

May 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe